231. Kelsen, S. G.+, Maurer, M., Waters, M., Dash, A., Fong, A., Mohan, D., Theess, W., Yang, X., Alvaro, G., and Brightling, C. E.: Safety and tolerability of astegolimab, an anti-ST2 monoclonal antibody: a narrative review. Resp. Res. 2025: 26; 302. IF: 5.70 r.231
230. Bernstein, J. A.+, Ansotegui, I., Asero, R., Banerji, A., Betschel, S., Craig, T., García-Abujeta, J. L., Gómez, R. M., Grumach, A. S., Hide, M., Lang, D. M., Levin, M., Longhurst, H. J., Maurer, M., Morais-Almeida, M., Van, D. N., Pité, H., Riedl, M. A., Rojo Gutiérrez, M. I., Saini, S. S., Sussman, G., Toubi,
|
229. |
Casale, T. B.+, Gimenez-Arnau, A. M., Bernstein, J. A., Holden, M., Zuberbier, T., Maurer, M.: A plain language summary of a review about omalizumab for people with chronic spontaneous urticaria. Immunotherapy 2025: 17; 239-245. IF: TBD (IF 2024: 2.30) |
r.229
|
228. |
Heidarzadeh-Asl, S., Maurer, M., Kiani, A., Atiakshin, D., Stahl Skov, P., and Elieh-Ali-Komi, D.+: Novel insights on the biology and immunological effects of histamine: a road map for allergists and mast cell biologists. J. Allergy Clin. Immunol. 2025: 155; 1095-1114. IF: TBD (IF 2024: 11.20) |
r.228
|
227. |
Cohn, D. M., Soteres, D. F., Craig, T. J., Lumry, W. R., Magerl, M., Riedl, M. A., Audhya, P. K., Maurer, M., and Bernstein, J. A.+: Interplay between on-demand treatment trials for hereditary angioedema and treatment guidelines. J. Allergy Clin. Immunol. 2025: 155; 726-739. IF: TBD (IF 2024: 11.20) |
r.227
|
226. |
Zuraw, B. L.+*, Bork, K.*, Bouillet, L., Christiansen, S. C., Farkas, H., Germenis, A. E., Grumach, A. S., Kaplan, A., López-Lera, A., Magerl, M., Riedl, M. A., Adatia, A., Banerji, A., Betschel, S., Boccon-Gibod, I., Bova, M., Boysen, H. B., Caballero, T., Cancian, M., Castaldo, A. J., Cohn, D. M., Corcoran, D., Drouet, C., Fukunaga, A., Hide, M., Katelaris, C. H., Li, P. H., Longhurst, H., Peter, J., Psarros, F., Reshef, A., Ritchie, B., Selva, C. N., Zanichelli, A., and Maurer, M.*: Hereditary angioedema with normal C1 Inhibitor: an updated international consensus paper on diagnosis, pathophysiology, and treatment. Clin. Rev. Allergy Immunol. 2025: 68; 24. IF: TBD (IF 2024: 11.30) |
r.226
|
225. |
Elieh-Ali-Komi, D.+, Maurer, M., and Siebenhaar, F.: The impact of mast cells on the anatomy, cellular communication, and molecular immune network of lymph nodes. Clin. Rev. Allerg. Immunol. 2025: 68; 35. IF: TBD (IF 2024: 11.30) |
r.225
|
224. |
Elieh-Ali-Komi, D.+, Shafaghat, F.*, Alipoor, S. D.*, Kazemi, T., Atiakshin, D., Pyatilova, P., and Maurer, M.: Immunomodulatory significance of mast cell exosomes (MC-EXOs) in immune response coordination. Clin. Rev. Allerg. Immunol. 2025: 68; 20. IF: TBD (IF 2024: 11.30) |
r.224
|
223. |
Rothermel, N. D., Vera Ayala, C., Goncalo, M., Fok, J. S., Herzog, L. S., Kocatürk, E., Neisinger, S., Pereira, M. P., Podder, I., Pyatilova, P., Ramanauskaite, A., Munoz, M., Krause, K., Maurer, M., Bonnekoh, H., and Kolkhir, P.+: Managing urticarial vasculitis: a clinical decision-making algorithm based on expert consensus. Am. J. Clin. Dermatol. 2025: 26; 61-75. IF: TBD (IF 2024: 8.80) |
r.223
|
222. |
Kocatürk, E.+, and Maurer, M.: Acute urticaria management: gaps, challenges and the need for further evidence. J. Eur. Acad. Dermatol. Venereol. 2024: 38; 2047-2048. IF: 8.00 |
r.222
Acute urticaria management: gaps, challenges and the need for further evidence Read More »